Converge Bio Inc. — Form D

Converge Bio Inc. of CLAYMONT, DE, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-28. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (5)

NameRoleLocation
Dov GertzRelated PersonClaymont, DE
Andrew HedinRelated PersonClaymont, DE
Oded KalevRelated PersonClaymont, DE
Shahar TzafrirRelated PersonClaymont, DE
Iddo WeinerRelated PersonClaymont, DE

More